SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (4532)6/18/1998 4:00:00 PM
From: Bryan Arnold  Respond to of 6136
 
It is on CNN's web site but there is no mention of a "cancer cure" on that article. If anything, he downplays it by saying that it is only a Phase I study and we still have a long way to go before we can bring it to market.

Bryan



To: mike head who wrote (4532)6/18/1998 10:23:00 PM
From: billkirn  Read Replies (1) | Respond to of 6136
 
MikeHead: Thanks for your interpretation. I don't think AGPH needs any hype. The stock is building a very good base here and I expect the 2nd half of this year to show some price improvement; steady, grounded solid movement. If we can get 30% per year for the next 5 years we will all be happy.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News